Genmab at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Genmab brings 4 presentations to ASH 2026 in New Orleans, and exhibits at Booth 3229. Genmab supports symposia on bispecific antibodies in lymphoma and hosts a theater session on a bispecific for follicular and large B-cell lymphoma. Its research covers epcoritamab and a CD3 by FLT3 antibody for acute myeloid leukemia.
| Organization | ASH 2026 Attendance |
|---|---|
Genmab Copenhagen, Denmark | |
Danish antibody company developing bispecific antibodies and antibody-drug conjugates, including epcoritamab for lymphoma. | Booth Exhibiting at Booth 3229 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 11:00am–2:00pm Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials. Symposium Fri Dec 11 11:00am–2:00pm Bispecific Antibodies in Action: Applying Evidence Across the DLBCL and FL Care Continuum Bispecific antibodies in relapsed diffuse large B-cell and follicular lymphoma, from sequencing with CAR-T to outpatient step-up dosing and side effects. Symposium Fri Dec 11 3:00pm–6:00pm Optimizing Integration of BsAb-Based Therapies for FL and DLBCL: Expert Perspectives on New Standards and Future Directions How bispecific antibodies for follicular and diffuse large B-cell lymphoma differ in structure, dosing, and safety, and how to sequence them in community care. Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 12:15pm–1:15pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Genmab
Tell us what you sell and we’ll find the people at Genmab most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction